The prostate cancer risk stratification (ProCaRS) project: Recursive partitioning risk stratification analysis

Radiotherapy and Oncology

Volumn 109, Issue 2, 2013, Pages 204-210

  Rodrigues, George ^a   Lukka, Himu ^b   Warde, Padraig ^c   Brundage, Michael ^d   Souhami, Luis ^e   Crook, Juanita ^f   Cury, Fabio ^e   Catton, Charles ^c   Mok, Gary ^c   Martin, Andre Guy ^g   Vigneault, Eric ^g   Morris, Jim ^h   Warner, Andrew ^a   Gonzalez Maldonado, Sandra ^a   Pickles, Tom ^h  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b JURAVINSKI CANCER CENTRE   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d Kingston Regional Cancer Centre   (Canada)

^e MONTREAL GENERAL HOSPITAL   (Canada)

^f KELOWNA GENERAL HOSPITAL   (Canada)

^g LAVAL UNIVERSITY   (Canada)

^h BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Database; Prognosis; Prostatic neoplasms; Radiotherapy; Statistical model

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; BIOCHEMICAL FAILURE FREE SURVIVAL; BRACHYTHERAPY; CANADA; CANCER RADIOTHERAPY; CANCER RISK; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT;

DATABASE; PROGNOSIS; PROSTATIC NEOPLASMS; RADIOTHERAPY; STATISTICAL MODEL;

AGED; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROSTATIC NEOPLASMS; RISK;

EID: 84889578197     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.07.020     Document Type: Article

References (24)

1. U. Capitanio, A. Briganti, and A. Gallina Predictive models before and after radical prostatectomy Prostate 70 2010 1371 1378
2. F.K. Chun, P.I. Karakiewicz, and A. Briganti A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer BJU Int 99 2007 794 800
3. G. Rodrigues, P. Warde, and T. Pickles Pre-treatment risk stratification of prostate cancer patients: a critical review Can Urol Assoc J 6 2012 121 127
4. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
5. I. Thompson, J.B. Thrasher, and G. Aus Guideline for the management of clinically localized prostate cancer: 2007 update J Urol 177 2007 2106 2131
6. A. Heidenreich, G. Aus, and M. Bolla EAU guidelines on prostate cancer Eur Urol 53 2008 68 80
7. H. Lukka, P. Warde, T. Pickles, G. Morton, M. Brundage, and L. Souhami Controversies in prostate cancer radiotherapy: consensus development Can J Urol 8 2001 1314 1322
8. J. Graham, M. Baker, F. Macbeth, and V. Titshall Diagnosis and treatment of prostate cancer: summary of NICE guidance BMJ 336 2008 610 612
9. M.R. Cooperberg, D.P. Lubeck, S.S. Mehta, and P.R. Carroll Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE) J Urol 170 2003 S21 S25
10. A. Horwich, C. Parker, C. Bangma, and V. Kataja Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 21 2010 v129 v133
11. J.L. Mohler, A.J. Armstrong, and R.R. Bahnson Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines J Natl Compr Canc Netw 10 2012 1081 1087
12. A.G. Aprikian Risk stratification in clinically localized prostate cancer Can J Urol 9 2002 18 20
13. P. Sutcliffe, S. Hummel, and E. Simpson Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer: a systematic review Health Technol Assess 13 2009 1 219 (iii, xi-xiii)
14. G. Rodrigues, S. Gonzalez-Maldonado, and H. Lukka The prostate cancer risk stratification (ProCaRS) project: database construction and outcome analysis Int J Radiat Oncol Biol Phys 84 2012 S57
15. T. Pickles, W.J. Morris, M.W. Kattan, C. Yu, and M. Keyes Comparative 5-year outcomes of brachytherapy and surgery for prostate cancer Brachytherapy 10 2011 9 14
16. M. Roach 3rd, G. Hanks, and H. Thames Jr. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 2006 965 974
17. A. Thompson, M. Keyes, and T. Pickles Evaluating the Phoenix definition of biochemical failure after (125)I prostate brachytherapy: can PSA kinetics distinguish PSA failures from PSA bounces? Int J Radiat Oncol Biol Phys 78 2010 415 421
18. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
19. M. Roach 3rd, V. Weinberg, M. Nash, H.M. Sandler, P.W. McLaughlin, and M.W. Kattan Defining high risk prostate cancer with risk groups and nomograms: implications for designing clinical trials J Urol 176 2006 S16 S20
20. M. Beasley, S.G. Williams, and T. Pickles BCCA prostate outcomes unit. Expanded risk groups help determine which prostate radiotherapy sub-group may benefit from adjuvant androgen deprivation therapy Radiat Oncol 18 2008 8
21. S.G. Williams, G.M. Duchesne, and N.K. Gogna An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer risk Int J Radiat Oncol Biol Phys 65 2006 351 357
22. J.I. Epstein, P.C. Walsh, M. Carmichael, and C.B. Brendler Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368 374
23. J. Huang, F.A. Vicini, and S.G. Williams Percentage of positive biopsy cores: a better risk stratification model for prostate cancer? Int J Radiat Oncol Biol Phys 83 2012 1141 1148
24. S.G. Williams, T. Pickles, and M.K. Buyyounouski Androgen deprivation therapy and prostate cancer duration J Clin Oncol 27 2009 e228